Zhejiang Charioteer Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NAPROXEN USP (BULK), with a corresponding US DMF Number 18554.
Remarkably, this DMF maintains an Active status since its submission on July 25, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 22, 2014, and payment made on August 16, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II